Timothy J. Pigot

Timothy J. Pigot

Chief Commercial OfficersatJade Biosciences· In proxies 2022–2023

Pay in FY2023+433% from the year before · Jade Biosciences stock -22.8% the same year

Timothy J. Pigot was paid $2.5M in FY2023 (Dec), up 433%. Jade Biosciences stock fell 22.8% that year.

Pay$100 in the stock at the end of FY21 → $192
Pay is from the Summary Compensation Table of each Jade Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Jade BiosciencesPublic company · 4 yr
    • Chief Commercial Officers2022 – Present · 4 yrStock in role -62%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?